Standout Papers

Hyperactivity of the reticuloendothelial system and experimental anemia in mice. 1960 2026 1982 2004 2.5k
  1. Hyperactivity of the reticuloendothelial system and experimental anemia in mice. (1960)
    Fred Gorstein, Baruj Benacerraf PubMed
  2. Studies on the Pathogenesis of Experimental Immune Thyroiditis. (1961)
    P. A. Miescher, Fred Gorstein et al. Experimental Biology and Medicine
  3. Diagnosis of gastrointestinal stromal tumors: A consensus approach (2002)
    Christopher D.�M. Fletcher, Jules J. Berman et al. Human Pathology

Citation Impact

Citing Papers

Hereditary Anemias of the Mouse: A Review for Geneticists
1979
B7-H4 Expression in Human Melanoma: Its Association with Patients' Survival and Antitumor Immune Response
2011
Immunotype and Immunohistologic Characteristics of Tumor-Infiltrating Immune Cells Are Associated with Clinical Outcome in Metastatic Melanoma
2012
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
2004 StandoutScience
Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor
2003 Standout
Gastrointestinal stromal tumors in Iceland, 1990–2003: The Icelandic GIST study, a population‐based incidence and pathologic risk stratification study
2005
Aberrant chromosomal sex-determining mechanisms in mammals, with special reference to species with XY females
1988
Effects of an Rb mutation in the mouse
1992 StandoutNature
Gastrointestinal stromal tumors–a review
2004
Endometriotic disease: the role of peritoneal fluid
1998
Role of aromatase in endometrial disease
2001
Male development of chromosomally female mice transgenic for Sry
1991 StandoutNature
Gastrointestinal Stromal Tumors With KIT Exon 11 Deletions Are Associated With Poor Prognosis
2006
Regulation of Aromatase Expression in Estrogen-Responsive Breast and Uterine Disease: From Bench to Treatment
2005
Gastrointestinal stromal tumour
2007
Current Concepts in the Pathogenesis of Endometriosis
1999
Paracrine Regulation of Matrix Metalloproteinase Expression in Endometriosis
2002
Immune cells in primary gastrointestinal stromal tumors
2008
Regulatory T Cells
2000 StandoutNobel
Endometriosis
2009 Standout
The Prognostic Implications of Microscopic Satellites in Patients With Clinical Stage I Melanoma
1991
Gastrointestinal stromal tumors: Pathology and prognosis at different sites
2006 Standout
Dermatologist-level classification of skin cancer with deep neural networks
2017 StandoutNature
Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing
2011 Standout
Targeting the molecular pathophysiology of gastrointestinal stromal tumors with imatinib
2002
MMP-9/Gelatinase B Is a Key Regulator of Growth Plate Angiogenesis and Apoptosis of Hypertrophic Chondrocytes
1998 Standout
Sentinel-Node Biopsy or Nodal Observation in Melanoma
2006 Standout
Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses. Discrimination of benign from malignant disease
1988
Incidence of gastrointestinal stromal tumours is underestimated: Results of a nation-wide study
2005
Soft-Tissue Sarcomas in Adults
2005 Standout
Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system.
1997
Cutaneous melanoma: Prognosis and treatment results worldwide
1992
Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978–2001: An analysis of 26,758 cases
2006 Standout
Response to imatinib mesylate of a gastrointestinal stromal tumor with very low expression of KIT
2003
The bone marrow niche for haematopoietic stem cells
2014 StandoutNature
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
2007 Standout
Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
1997 Standout
Management of malignant gastrointestinal stromal tumours
2002
Paracrine Regulation of Matrix Metalloproteinase Expression in the Normal Human Endometrium
1999
A prospective epidemiological study of new incident GISTs during two consecutive years in Rhône Alpes region: incidence and molecular distribution of GIST in a European region
2010
The role of progestins in treating the pain of endometriosis
2006
Endometriosis, retrograde menstruation and peritoneal inflammation in women and in baboons
2002
High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis
1993 Standout
Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target
1999
Drug Insight: gastrointestinal stromal tumors (GIST)—the solid tumor model for cancer-specific treatment
2008
Expression of Cytokeratins 17 and 5 Identifies a Group of Breast Carcinomas with Poor Clinical Outcome
2002
Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era
2005
Model Predicting Survival in Stage I Melanoma Based on Tumor Progression
1989 Standout
Distinct Sets of Genetic Alterations in Melanoma
2005 Standout
Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair
1993 Standout
Cancer testis antigen expression in gastrointestinal stromal tumors: New markers for early recurrence
2008
Immunohistochemistry in the diagnosis of soft tissue tumours
2003
Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial
2004 Standout
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Human endometrial MUC1 carries keratan sulfate: characteristic glycoforms in the luminal epithelium at receptivity
1998
Aromatase as a Therapeutic Target in Endometriosis
2000
Prognostic Factors in Patients With Melanoma Metastatic to Axillary or Inguinal Lymph Nodes
1991
Patterns of Relapse in 1001 Consecutive Patients With Melanoma Nodal Metastases
1989
Endometriosis
2010 Standout
Crystal structure of a chimeric Fab′ fragment of an antibody binding tumour cells
1992
Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma
1994 Standout
A selective estrogen receptor-β agonist causes lesion regression in an experimentally induced model of endometriosis
2004
Axillary Dissection in Melanoma
1990
Deletion of Trp‐557 and Lys‐558 in the juxtamembrane domain of the c‐kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors
2003
Carotid-Artery Intima and Media Thickness as a Risk Factor for Myocardial Infarction and Stroke in Older Adults
1999 Standout
Successful treatment of severe endometriosis in two premenopausal women with an aromatase inhibitor
2004
Golgi Localization of Carbohydrate Sulfotransferases Is a Determinant of L-selectin Ligand Biosynthesis
2003 StandoutNobel
Endometriosis
2004 Standout
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
2015 StandoutNature
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
American Joint Committee on Cancer prognostic factors consensus conference
2000
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
2011 StandoutNobel
TGFα deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice
1993 StandoutNobel
Reduced progesterone action during endometrial maturation: A potential risk factor for the development of endometriosis
2005
Prognostic value of size of lymph node metastases in patients with cutaneous melanoma.
1995
Predicting five-year outcome for patients with cutaneous melanoma in a population-based study
1996
Treating endometriosis as an autoimmune disease
2001
Prevalence of Patent Foramen Ovale in Patients with Stroke
1988 Standout
Pathogenesis of endometriosis
2004
The prognosis of patients with stage III melanoma prospective long-term study of 286 patients of the fachklinik hornheide
1993
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
2004 Standout
The cancer genome
2009 StandoutNature
Flow Patterns in Vessels of Simple and Complex Geometriesa
1987
Cancer of the Ovary
2004 Standout
NaturallyArisingCD4+RegulatoryT Cells forImmunologicSelf-Tolerance andNegativeControl ofImmuneResponses
2003 StandoutNobel
The journey of developing hematopoietic stem cells
2006
Transcriptional Characterizations of Differences between Eutopic and Ectopic Endometrium
2005
Thymus and autoimmunity: capacity of the normal thymus to produce pathogenic self-reactive T cells and conditions required for their induction of autoimmune disease.
1990 StandoutNobel
Analysis of Autoimmunity through Experimental Models of Thyroiditis and Allergic Encephalomyelitis
1980
Repeated observation of breast tumor subtypes in independent gene expression data sets
2003 Standout
Prognostic Factors in Patients with Advanced Renal Cell Carcinoma
2004
A Comparison of Prognostic Factors and Surgical Results in 1,786 Patients with Localized (Stage I) Melanoma Treated in Alabama, USA, and New South Wales, Australia
1982
Dissections of Cervical and Cerebral Arteries
1983
Biology of Gastrointestinal Stromal Tumors
2004 Standout
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation
1996
Immune Versus Natural Selection: Antibody Aldolases with Enzymic Rates But Broader Scope
1997 StandoutScienceNobel
Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors
1998 StandoutScience
The Risk of In-Transit Melanoma Metastasis Depends on Tumor Biology and Not the Surgical Approach to Regional Lymph Nodes
2005
Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors.
2003
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
2003 StandoutNobel
Prognostic factors for stagei melanoma of the skin: A review
1985
Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-1 cells in normal female mice for the prevention of oophoritis.
1982 StandoutNobel
Prognostic Value ofKITMutation Type, Mitotic Activity, and Histologic Subtype in Gastrointestinal Stromal Tumors
2002
In Vivo Evidence That the Stromelysin-3 Metalloproteinase Contributes in a Paracrine Manner to Epithelial Cell Malignancy
1998
Endometriosis
2020 Standout
Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
2001 Standout
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
2002 StandoutScience
A mouse model for beta 0-thalassemia.
1995 StandoutNobel
Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix.
1996
Prognostic Factors in Patients with Melanoma Metastatic to Regional Nodes
1992
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
2005 Standout
Angiogenesis extent and expression of matrix metalloproteinase‐2 and ‐9 correlate with upgrading and myometrial invasion in endometrial carcinoma
1999
High Prognostic Value of p16INK4 Alterations in Gastrointestinal Stromal Tumors
2003
Prognostic histopathological factors in malignant melanoma
1985
Genes Expressed in Human Tumor Endothelium
2000 StandoutScience
Tissue-specific expression of B7x protects from CD4 T cell–mediated autoimmunity
2011 StandoutNobel
Thickening of the Carotid Wall
1996
Cutaneous Malignant Melanoma: Prognostic Guidelines for Physicians and Patients
1982
American Joint Committee on Cancer Prognostic Factors Consensus Conference
1999

Works of Fred Gorstein being referenced

Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle
1993
Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones.
1994
Monoclonal Antibody B72.3 Reactivity with Human Endometrium
1987
Diagnosis of gastrointestinal stromal tumors: A consensus approach
2002 Standout
Progesterone and transforming growth factor-β coordinately regulate suppression of endometrial matrix metalloproteinases in a model of experimental endometriosis
1999
Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice.
1997
A Prognostic Model for Clinical Stage I Melanoma of the Upper Extremity. The Importance of Anatomic Subsites in Predicting Recurrent Disease
1981
Studies on the Pathogenesis of Experimental Immune Thyroiditis.
1961 StandoutNobel
Atherosclerotic Subintimai Hematoma of the Carotid Artery
1979
Malignant melanoma patients with positive nodes and relatively good prognoses: Microstaging retains prognostic significance in clinical stage I melanoma patients with metastases to regional nodes
1981
Treatment of hypoplastic anemia in mice with placental transplants
1977
A prognostic model for clinical stage I melanoma of the trunk
1981
Diagnosis of Gastrointestinal Stromal Tumors:A Consensus Approach
2002
Hematopoietic cells in mouse placenta
1968
An X-O Anomaly and Ovarian Dysgenesis in a Rhesus Monkey
1973
College of American Pathologists Conference XXVI on clinical relevance of prognostic markers in solid tumors. Summary. Members of the Cancer Committee.
1995
Tumor-Associated Glycoprotein (TAG-72) in Ovarian Carcinomas Defined by Monoclonal Antibody 872.3
1986
The carotid bifurcation plaque: pathologic findings associated with cerebral ischemia.
1979
Malignant Melanoma
1981
Stromal-epithelial interaction mediates steroidal regulation of metalloproteinase expression in human endometrium.
1994
Stromal-epithelial cell communication, growth factors, and tissue regulation.
1990
A prognostic model for clinical stage I melanoma of the lower extremity. Location on foot as independent risk factor for recurrent disease.
1981
Rankless by CCL
2026